Surgery and radiotherapy for retroperitoneal and abdominal sarcoma: Both necessary and sufficient

Archives of Surgery

Volumn 145, Issue 5, 2010, Pages 426-431

  Zhou, Zheng ^a   McDade, Theodore P ^a   Simons, Jessica P ^a   Ng, Sing Chau ^a   Lambert, Laura A ^a   Whalen, Giles F ^a   Shah, Shimul A ^a   Tseng, Jennifer F ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL TUMOR; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIMARY TUMOR; PRIORITY JOURNAL; RACE DIFFERENCE; RETROPERITONEAL SARCOMA; RETROSPECTIVE STUDY; SARCOMA; SURVIVAL RATE; THERAPY EFFECT;

COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; RETROPERITONEAL NEOPLASMS; RETROSPECTIVE STUDIES; SARCOMA; SEER PROGRAM; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77952416453     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.2010.70     Document Type: Article

References (27)

1. Liles JS, Tzeng CW, Short JJ, Kulesza P, Heslin MJ. Retroperitoneal and intra-abdominal sarcoma. Curr Probl Surg. 2009;46(6):445-503.
2. Jemal A, Siegel R, Ward E, et al. Cancer statistics 2008. CA Cancer J Clin. 2008;58(2):71-96.
3. Thomas JM. Retroperitoneal sarcoma. Br J Surg. 2007;94(9):1057-1058.
4. van Dalen T, Plooij JM, van Coevorden F, et al; Dutch Soft Tissue Sarcoma Group. Long-term prognosis of primary retroperitoneal soft tissue sarcoma. Eur J Surg Oncol. 2007;33(2):234-238.
5. Chiappa A, Zbar AP, Bertani E, et al. Primary and recurrent retroperitoneal soft tissue sarcoma: prognostic factors affecting survival. J Surg Oncol. 2006;93(6):456-463. (Pubitemid 44651268)
6. Mäkelä J, Kiviniemi H, Laitinen S. Prognostic factors predicting survival in the treatment of retroperitoneal sarcoma. Eur J Surg Oncol. 2000;26(6):552-555.
7. Demetri GD, Antonia S, Benjamin RS, et al. Soft tissue sarcoma. In: NCCN Clinical Practice Guidelines in Oncology. Fort Washington, PA: National Comprehensive Cancer Network; 2009.
8. Katz MH, Choi EA, Pollock RE. Current concepts in multimodality therapy for retroperitoneal sarcoma. Expert Rev Anticancer Ther. 2007;7(2):159-168.
9. Gronchi A, Lo Vullo S, Fiore M, et al. Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol. 2009;27(1):24-30.
10. Ballo MT, Zagars GK, Pollock RE, et al. Retroperitoneal soft tissue sarcoma: an analysis of radiation and surgical treatment. Int J Radiat Oncol Biol Phys. 2007;67(1):158-163. (Pubitemid 44959494)
11. Feng M, Murphy J, Griffith KA, et al. Long-term outcomes after radiotherapy for retroperitoneal and deep truncal sarcoma. Int J Radiat Oncol Biol Phys. 2007;69(1):103-110. (Pubitemid 47247511)
12. Zlotecki RA, Katz TS, Morris CG, Lind DS, Hochwald SN. Adjuvant radiation therapy for resectable retroperitoneal soft tissue sarcoma: the University of Florida experience. Am J Clin Oncol. 2005;28(3):310-316. (Pubitemid 40800485)
13. Gilbeau L, Kantor G, Stoeckle E, et al. Surgical resection and radiotherapy for primary retroperitoneal soft tissue sarcoma. Radiother Oncol. 2002;65(3):137-143. (Pubitemid 35441044)
14. Pirayesh A, Chee Y, Helliwell TR, et al. The management of retroperitoneal soft tissue sarcoma: a single institution experience with a review of the literature. Eur J Surg Oncol. 2001;27(5):491-497. (Pubitemid 32694605)
15. Gloeckler Ries LA, Ward KC, Young JLJ. Sarcoma. In: SEER Survival Monograph. Bethesda, MD: National Cancer Institute, SEER Program; 2007:89-92.
16. Hill JS, McPhee JT, McDade TP, et al. Pancreatic neuroendocrine tumors: the impact of surgical resection on survival. Cancer. 2009;115(4):741-751.
17. World Health Organization; Fritz A, Percy C, Jack A, et al, eds. International Classification of Diseases for Oncology, 3rd Edition. Geneva, Switzerland: World Health Organization; 2005.
18. Porter GA, Baxter NN, Pisters PW. Retroperitoneal sarcoma: a population-based analysis of epidemiology, surgery, and radiotherapy. Cancer. 2006;106(7):1610-1616.
19. Dupre ME, Beck AN, Meadows SO. Marital trajectories and mortality among US adults. Am J Epidemiol. 2009;170(5):546-555.
20. Gnerlich J, Dueker JM, Jeffe DB, Deshpande AD, Thompson S, Margenthaler JA. Patient and tumor characteristics associated with primary tumor resection in women with Stage IV breast cancer: analysis of 1988-2003 SEER data. Breast J. 2008;14(6):538-542.
21. AJCC Staging Manual. 6th ed. New York, NY: Springer-Verlag; 2002.
22. Mendenhall WM, Zlotecki RA, Hochwald SN, Hemming AW, Grobmyer SR, Cance WG. Retroperitoneal soft tissue sarcoma. Cancer. 2005;104(4):669-675.
23. Stoeckle E, Coindre JM, Bonvalot S, et al; French Federation of Cancer Centers Sarcoma Group. Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer. 2001;92(2):359-368.
24. Pawlik TM, Pisters PW, Mikula L, et al. Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate- or highgrade retroperitoneal soft tissue sarcoma. Ann Surg Oncol. 2006;13(4):508-517.
25. Pisters PW, Ballo MT, Fenstermacher MJ, et al. Phase I trial of preoperative concurrent doxorubicin and radiation therapy, surgical resection, and intraoperative electron-beam radiation therapy for patients with localized retroperitoneal sarcoma. J Clin Oncol. 2003;21(16):3092-3097.
26. White JS, Biberdorf D, DiFrancesco LM, Kurien E, Temple W. Use of tissue expanders and pre-operative external beam radiotherapy in the treatment of retroperitoneal sarcoma. Ann Surg Oncol. 2007;14(2):583-590. (Pubitemid 46178333)
27. Karakousis CP, Kontzoglou K, Driscoll DL. Intraperitoneal chemotherapy in disseminated abdominal sarcoma. Ann Surg Oncol. 1997;4(6):496-498. (Pubitemid 127725223)